{
  "paper_metadata": {
    "pmid": "31346352",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted variants in the BRCA2 gene along with penetrance data from the study."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.C5645A",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "VUS",
      "patients": {
        "count": 3,
        "demographics": "Ages 26 to 66, sex not specified",
        "phenotype": "Infiltrating ductal carcinoma, ductal carcinoma in situ, invasive lobular carcinoma, ovarian adenocarcinoma, primary peritoneal carcinoma"
      },
      "penetrance_data": {
        "total_carriers_observed": 3,
        "affected_count": 2,
        "unaffected_count": 1,
        "uncertain_count": null,
        "penetrance_percentage": 66.67,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case 1",
          "age_at_evaluation": 26,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Infiltrating ductal carcinoma",
          "evidence_sentence": "The eleven patients studied carried diagnoses of infiltrating ductal carcinoma, ductal carcinoma in situ, invasive lobular carcinoma, ovarian adenocarcinoma and primary peritoneal carcinoma."
        },
        {
          "individual_id": "Case 2",
          "age_at_evaluation": 66,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Ovarian adenocarcinoma",
          "evidence_sentence": "The eleven patients studied carried diagnoses of infiltrating ductal carcinoma, ductal carcinoma in situ, invasive lobular carcinoma, ovarian adenocarcinoma and primary peritoneal carcinoma."
        },
        {
          "individual_id": "Case 3",
          "age_at_evaluation": 40,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "unaffected",
          "phenotype_details": "No cancer diagnosis",
          "evidence_sentence": "Somatic BRCA2 variants were observed in three tumors, two of which were from BRCA1 phenocopies."
        }
      ],
      "functional_data": {
        "summary": "BRCA2 variants were found in tumors from BRCA1 phenocopies.",
        "assays": [
          "Next generation sequencing"
        ]
      },
      "segregation_data": "Not specified",
      "population_frequency": null,
      "evidence_level": "Limited evidence due to small sample size",
      "source_location": "Results, paragraph 4",
      "additional_notes": "Variants were found in tumors but not in germline testing.",
      "key_quotes": [
        "Somatic BRCA2 variants were observed in three tumors, two of which were from BRCA1 phenocopies."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.G8107A",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "VUS",
      "patients": {
        "count": 3,
        "demographics": "Ages 26 to 66, sex not specified",
        "phenotype": "Infiltrating ductal carcinoma, ductal carcinoma in situ, invasive lobular carcinoma, ovarian adenocarcinoma, primary peritoneal carcinoma"
      },
      "penetrance_data": {
        "total_carriers_observed": 3,
        "affected_count": 2,
        "unaffected_count": 1,
        "uncertain_count": null,
        "penetrance_percentage": 66.67,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case 1",
          "age_at_evaluation": 26,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Infiltrating ductal carcinoma",
          "evidence_sentence": "The eleven patients studied carried diagnoses of infiltrating ductal carcinoma, ductal carcinoma in situ, invasive lobular carcinoma, ovarian adenocarcinoma and primary peritoneal carcinoma."
        },
        {
          "individual_id": "Case 2",
          "age_at_evaluation": 66,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Ovarian adenocarcinoma",
          "evidence_sentence": "The eleven patients studied carried diagnoses of infiltrating ductal carcinoma, ductal carcinoma in situ, invasive lobular carcinoma, ovarian adenocarcinoma and primary peritoneal carcinoma."
        },
        {
          "individual_id": "Case 3",
          "age_at_evaluation": 40,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "unaffected",
          "phenotype_details": "No cancer diagnosis",
          "evidence_sentence": "Somatic BRCA2 variants were observed in three tumors, two of which were from BRCA1 phenocopies."
        }
      ],
      "functional_data": {
        "summary": "BRCA2 variants were found in tumors from BRCA1 phenocopies.",
        "assays": [
          "Next generation sequencing"
        ]
      },
      "segregation_data": "Not specified",
      "population_frequency": null,
      "evidence_level": "Limited evidence due to small sample size",
      "source_location": "Results, paragraph 4",
      "additional_notes": "Variants were found in tumors but not in germline testing.",
      "key_quotes": [
        "Somatic BRCA2 variants were observed in three tumors, two of which were from BRCA1 phenocopies."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.6794 insA",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "VUS",
      "patients": {
        "count": 3,
        "demographics": "Ages 26 to 66, sex not specified",
        "phenotype": "Infiltrating ductal carcinoma, ductal carcinoma in situ, invasive lobular carcinoma, ovarian adenocarcinoma, primary peritoneal carcinoma"
      },
      "penetrance_data": {
        "total_carriers_observed": 3,
        "affected_count": 2,
        "unaffected_count": 1,
        "uncertain_count": null,
        "penetrance_percentage": 66.67,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case 1",
          "age_at_evaluation": 26,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Infiltrating ductal carcinoma",
          "evidence_sentence": "The eleven patients studied carried diagnoses of infiltrating ductal carcinoma, ductal carcinoma in situ, invasive lobular carcinoma, ovarian adenocarcinoma and primary peritoneal carcinoma."
        },
        {
          "individual_id": "Case 2",
          "age_at_evaluation": 66,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Ovarian adenocarcinoma",
          "evidence_sentence": "The eleven patients studied carried diagnoses of infiltrating ductal carcinoma, ductal carcinoma in situ, invasive lobular carcinoma, ovarian adenocarcinoma and primary peritoneal carcinoma."
        },
        {
          "individual_id": "Case 3",
          "age_at_evaluation": 40,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "unaffected",
          "phenotype_details": "No cancer diagnosis",
          "evidence_sentence": "Somatic BRCA2 variants were observed in three tumors, two of which were from BRCA1 phenocopies."
        }
      ],
      "functional_data": {
        "summary": "BRCA2 variants were found in tumors from BRCA1 phenocopies.",
        "assays": [
          "Next generation sequencing"
        ]
      },
      "segregation_data": "Not specified",
      "population_frequency": null,
      "evidence_level": "Limited evidence due to small sample size",
      "source_location": "Results, paragraph 4",
      "additional_notes": "Variants were found in tumors but not in germline testing.",
      "key_quotes": [
        "Somatic BRCA2 variants were observed in three tumors, two of which were from BRCA1 phenocopies."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.6174 del T",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "VUS",
      "patients": {
        "count": 3,
        "demographics": "Ages 26 to 66, sex not specified",
        "phenotype": "Infiltrating ductal carcinoma, ductal carcinoma in situ, invasive lobular carcinoma, ovarian adenocarcinoma, primary peritoneal carcinoma"
      },
      "penetrance_data": {
        "total_carriers_observed": 3,
        "affected_count": 2,
        "unaffected_count": 1,
        "uncertain_count": null,
        "penetrance_percentage": 66.67,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case 1",
          "age_at_evaluation": 26,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Infiltrating ductal carcinoma",
          "evidence_sentence": "The eleven patients studied carried diagnoses of infiltrating ductal carcinoma, ductal carcinoma in situ, invasive lobular carcinoma, ovarian adenocarcinoma and primary peritoneal carcinoma."
        },
        {
          "individual_id": "Case 2",
          "age_at_evaluation": 66,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Ovarian adenocarcinoma",
          "evidence_sentence": "The eleven patients studied carried diagnoses of infiltrating ductal carcinoma, ductal carcinoma in situ, invasive lobular carcinoma, ovarian adenocarcinoma and primary peritoneal carcinoma."
        },
        {
          "individual_id": "Case 3",
          "age_at_evaluation": 40,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "unaffected",
          "phenotype_details": "No cancer diagnosis",
          "evidence_sentence": "Somatic BRCA2 variants were observed in three tumors, two of which were from BRCA1 phenocopies."
        }
      ],
      "functional_data": {
        "summary": "BRCA2 variants were found in tumors from BRCA1 phenocopies.",
        "assays": [
          "Next generation sequencing"
        ]
      },
      "segregation_data": "Not specified",
      "population_frequency": null,
      "evidence_level": "Limited evidence due to small sample size",
      "source_location": "Results, paragraph 4",
      "additional_notes": "Variants were found in tumors but not in germline testing.",
      "key_quotes": [
        "Somatic BRCA2 variants were observed in three tumors, two of which were from BRCA1 phenocopies."
      ]
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 1",
      "table_caption": "Variants with potential clinical significance.",
      "variants_extracted": 4
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 4,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All variants extracted were in the BRCA2 gene."
  }
}